Medicare Enrolled

Dr. Sitamahalakshmi Yerramalli, MD

Hematology & Oncology · Belleville, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1 CLARA MAASS DR STE 200, Belleville, NJ 07109
9737518880
In practice since 2005 (20 years)
NPI: 1780676759 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yerramalli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yerramalli? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yerramalli

Dr. Sitamahalakshmi Yerramalli is a hematology & oncology specialist in Belleville, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yerramalli performed 1,751 Medicare services across 510 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yerramalli received a total of $5,025 from 57 pharmaceutical and/or device companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yerramalli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,751 Medicare services $5,025 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,751
Medicare services
Bottom 49% in NJ for hematology & oncology
510
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
562 $8 $8
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
556 $8 $17
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
394 $106 $291
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
92 $13 $33
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $66 $201
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
56 $58 $153
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $144 $375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
5.3% medium
91.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,025
Total received (2018-2024)
Avg $718/year across 7 years
Top 41% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,449 (88.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$576 (11.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,188
2023
$825
2022
$559
2021
$359
2020
$260
2019
$1,089
2018
$745

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$197
E.R. Squibb & Sons, L.L.C.
$180
Daiichi Sankyo Inc.
$73
Adaptive Biotechnologies Corporation
$63
Janssen Biotech, Inc.
$61
Incyte Corporation
$60
GlaxoSmithKline, LLC.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$47
Merck Sharp & Dohme LLC
$46
GENZYME CORPORATION
$41
Regeneron Healthcare Solutions, Inc.
$37
BeiGene USA, Inc.
$35
Novartis Pharmaceuticals Corporation
$30
PUMA BIOTECHNOLOGY, INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
Acera Surgical, Inc.
$26
ABBVIE INC.
$20
Lilly USA, LLC
$20
Karyopharm Therapeutics Inc.
$19
Legend Biotech USA Inc.
$19
Eisai Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
PFIZER INC.
$17
EMD Serono, Inc.
$17
SOBI, INC
$15
Celgene Corporation
$15
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$545
E.R. Squibb & Sons, L.L.C.
$350
Novartis Pharmaceuticals Corporation
$348
Amgen Inc.
$329
Incyte Corporation
$314
Merck Sharp & Dohme Corporation
$167
Seagen Inc.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$164
Janssen Biotech, Inc.
$158
PFIZER INC.
$156
Karyopharm Therapeutics Inc.
$150
Celgene Corporation
$144
Pharmacyclics LLC, An AbbVie Company
$130
Lilly USA, LLC
$118
Daiichi Sankyo Inc.
$105
Seattle Genetics, Inc.
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Merck Sharp & Dohme LLC
$90
BeiGene USA, Inc.
$89
ASD SPECIALTY HEALTHCARE, LLC
$87
GlaxoSmithKline, LLC.
$74
Bayer HealthCare Pharmaceuticals Inc.
$67
Alexion Pharmaceuticals, Inc.
$67
Gilead Sciences, Inc.
$66
Puma Biotechnology, Inc.
$64
Adaptive Biotechnologies Corporation
$63
GENZYME CORPORATION
$56
Bayer Healthcare Pharmaceuticals Inc.
$54
Regeneron Healthcare Solutions, Inc.
$53
Exelixis Inc.
$47
CTI BioPharma Corp.
$45
EISAI INC.
$43
Eisai Inc.
$37
Janssen Pharmaceuticals, Inc
$32
PUMA BIOTECHNOLOGY, INC.
$30
Pharmacyclics LLC, an AbbVie Company
$29
Ipsen Biopharmaceuticals, Inc
$28
Advanced Accelerator Applications
$27
Acera Surgical, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$24
Verastem, Inc.
$23
AbbVie, Inc.
$23
Rigel Pharmaceuticals, Inc.
$22
ABBVIE INC.
$20
Sirtex Medical Inc
$19
Legend Biotech USA Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
EMD Serono, Inc.
$17
G1 Therapeutics, Inc.
$15
Fortovia Therapeutics, Inc.
$15
SOBI, INC
$15
Otsuka America Pharmaceutical, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
Janssen Scientific Affairs, LLC
$14
Servier Pharmaceuticals LLC
$13
Mylan Institutional Inc.
$12
Kite Pharma, Inc.
$12
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · BENDEKA · BRUKINSA · Balversa · Blincyto · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · ELITEK · EMEND · ENHERTU · EPKINLY · ERLEADA · Enhertu · FERAHEME · Fabhalta · Fulphila · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lutathera · MONJUVI · MONOFERRIC · MVASI · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONCASPAR · OPDIVO · OPDUALAG · Onivyde · PADCEV · PIQRAY · PROMACTA · REBLOZYL · RETEVMO · RYDAPT · Restrata Wound Matrix · Revlimid · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TASIGNA · Tavalisse · Trodelvy · Truxima · ULTOMIRIS · Ultomiris · VERZENIO · VIAGRA · VONJO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Belleville?
Compare hematology & oncology specialists in the Belleville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
702
Per 100K population
82.2
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yerramalli is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yerramalli experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Yerramalli performed 562 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yerramalli receive payments from pharmaceutical companies?
Yes. Dr. Yerramalli received a total of $5,025 from 57 companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yerramalli's costs compare to other hematology & oncology specialists in Belleville?
Dr. Yerramalli's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yerramalli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →